Nyctea Technologies is on Ny Teknik #33listan!! ⚡ We are so happy to be named among the most interesting and promising new companies in Sweden 2023! The recognition comes in a year when Nyctea has moved into BioVentureHub and sold our product to some of the largest biopharma companies in the world. Founder and CEO Gustav Ferrand-Drake del Castillo - "We are honored to be listed on #33listan. It was a dream of mine to qualify on this list back when we founded the company. This gives us energy to keep pushing the boundaries of innovation and redefine pharmaceutical manufacturing!" Thanks to the Nyctea team and support from our investors, Pontus, Daniel Langkilde, SkagerackVentures and Chalmers Ventures!
Såklart ni är! 👏🏻👏🏻
Great news, congratulations to the Nyctea team!
Senior Advisor to Vice President of Utilization
7moWoop woop!!! There is no doubt that you belong on that list! Great work!